Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Agendia; Gen-Probe, Neogen; Synthetic Biology Industry Association; Biodesign Institute, Intel

NEW YORK (GenomeWeb News) – Agendia this week said that Palmetto GBA, California's Part B Medicare administrator, has established coding guidelines for the firm's MammaPrint test. It said patients in the US can now submit claims for the MammaPrint test directly to Palmetto GBA in California where the test results are analyzed.

Gen-Probe has sold its BioKits food safety business to Neogen for an undisclosed sum. Gen-Probe acquired the BioKits business through its purchase earlier this year of Tepnel, but the business did not fit in with its long-term strategic plan. The BioKits line includes more than 50 test kits for food allergens, meat and fish speciation, and plant genomics. It brought in revenues of around $3 million in 2009, said Neogen.

The Synthetic Biology Industry Association was launched last week in Cambridge, Mass., and includes representatives of febit, Geneart, Ginkgo bioWorks, Biosearch Technologies, and Sutro Biopharma. The association will serve as a trade group for firms and individuals involved in gene synthesis, pharmaceutical development, energy development, and pollution control.

Arizona State University's Biodesign Institute will use $2.3 million worth of donated equipment from Intel to develop peptide chips for disease diagnosis. The institute said that the home-based tests would enable detection of disease at its earlier stage, even before symptoms are present.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.